This compound is primarily utilized in organic synthesis, particularly in the preparation of chiral intermediates for pharmaceuticals. Its structure, featuring a tert-butyl carbamate group and a chloro-hydroxypropyl moiety, makes it a valuable building block in the development of active pharmaceutical ingredients (APIs). It is often employed in the synthesis of beta-blockers and other cardiovascular drugs, where the chiral center plays a critical role in the drug's efficacy. Additionally, its protective group (tert-butyl carbamate) can be selectively removed under mild conditions, allowing for further functionalization in multi-step synthetic routes. The compound is also used in research for developing novel therapeutic agents due to its versatility and stability.